Product Information
LEVO-T 137 MCG TABLET is a generic product labeled by Neolpharma, Inc., priced at $0.0627 per EA under NDC 55466011111. Its NADAC has been published 525 times since Aug 3, 2016.
FDA first approved this application on Mar 1, 2002. Its Orange Book therapeutic-equivalence code is AB1,AB2,AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
137 ug/1
Manufacturer
Neolpharma, Inc.NDC
55466011111
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021342FDA Approved
3/1/2002
TE Code
AB1,AB2,AB3
On Market Since
10/29/2015
Pharmacological Classes
Price Statistics
The NADAC for LEVO-T 137 MCG TABLET has been published 525 times since Aug 3, 2016, and over the history we have for it it has declined 86.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0627 per EA |
|---|---|
| All-time high | $0.4976 (Oct 12, 2016) |
| All-time low | $0.0555 (Jul 17, 2024) |
| 52-week high | $0.0755 |
| 52-week low | $0.0624 |
| Median price | $0.2999 |
| Average price | $0.2661 |
| Largest weekly change | +51.0% (Jun 19, 2024) |
| Weeks tracked | 525 |
| Tracking since | Aug 3, 2016 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVO-T 137 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVO-T 137 MCG TABLET, manufactured by Neolpharma, Inc., is $0.0627 per EA (NDC 55466011111), effective Aug 19, 2026.
How has the price of LEVO-T 137 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVO-T 137 MCG TABLET has declined 86.3%. It has been tracked across 525 weekly CMS publications since Aug 3, 2016.
What are the highest and lowest recorded NADAC prices for LEVO-T 137 MCG TABLET?
Since Aug 3, 2016, the NADAC for LEVO-T 137 MCG TABLET has ranged from a low of $0.0555 (Jul 17, 2024) to a high of $0.4976 (Oct 12, 2016), with a median of $0.2999 per EA.
Are there cheaper alternatives to LEVO-T 137 MCG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVO-T 137 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVO-T 137 MCG TABLET?
LEVO-T 137 MCG TABLET (NDC 55466011111) is labeled by Neolpharma, Inc., and CMS classifies it as a generic product.